» Articles » PMID: 33059886

Lifestyle Modifications Alone or Combined with Hormonal Contraceptives Improve Sexual Dysfunction in Women with Polycystic Ovary Syndrome

Abstract

Objective: To describe the prevalence of female sexual dysfunction in a well-defined polycystic ovary syndrome (PCOS) population, and to assess the impact of common PCOS treatments on sexual function.

Design: Secondary analysis of a randomized controlled trial, oral contraceptive pills and weight loss in PCOS.

Setting: Two academic medical centers.

Patients: Women with PCOS (N = 114) defined by the Rotterdam criteria.

Interventions: Continuous oral contraceptive pill (OCP) or intensive lifestyle modification (Lifestyle) or the combination (Combined) for 16 weeks.

Main Outcome Measures: Change in Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Revised (FSDS-R) scores after 16 weeks.

Results: There was no change in total FSFI or FSDS-R score in any treatment group; however, an increase in the FSFI desire domain subscore was observed in the Lifestyle and Combined treatments, indicating improved sexual desire over the 16-week period. Overall, 33 participants (28.9%) met criteria for sexual dysfunction by FSFI criteria (baseline score ≤26.55). Among this group, FSFI score improved after 16 weeks of Lifestyle and Combined treatments. There was no change in prevalence of sexual dysfunction in treatment groups at 16 weeks. Use of OCPs did not alter FSFI scores.

Conclusion(s): Female sexual dysfunction is highly prevalent among women with PCOS. Our findings suggest that common treatments for PCOS, including intensive lifestyle modification and the combination of intensive lifestyle modification and OCPs, have the potential to improve sexual function in these women; the mechanism for these improvements is likely multifactorial.

Clinical Trial Registration Number: NCT00704912.

Citing Articles

Body shape concerns, sexual satisfaction, and associated factors among patients with polycystic ovarian syndrome: A cross-sectional study in Western Saudi Arabia.

Alsaidan A, Thirunavukkarasu A, Alsulami H Saudi Med J. 2025; 46(1):94-101.

PMID: 39779357 PMC: 11717095. DOI: 10.15537/smj.2025.46.1.20240797.


Total and bioavailable 25-hydroxyvitamin D is not associated with improved sexual dysfunction following vitamin D supplementation in women with polycystic ovarian syndrome: a pilot study.

Eickman K, Maxwell R, McGinnis L, Stanczyk F, Legro R, Lindheim S J Sex Med. 2024; 21(3):240-247.

PMID: 38303661 PMC: 10906494. DOI: 10.1093/jsxmed/qdad176.


Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Pastoor H, Mousa A, Bolt H, Bramer W, Burgert T, Dokras A Hum Reprod Update. 2024; 30(3):323-340.

PMID: 38237144 PMC: 11063549. DOI: 10.1093/humupd/dmad034.


Sexual dysfunction in women with PCOS: a case control study.

Pastoor H, Both S, Laan E, Laven J Hum Reprod. 2023; 38(11):2230-2238.

PMID: 37776157 PMC: 10628505. DOI: 10.1093/humrep/dead193.


Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review.

Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay C Clin Endocrinol (Oxf). 2023; 99(1):79-91.

PMID: 36939017 PMC: 10952804. DOI: 10.1111/cen.14913.


References
1.
Rellini A, Stratton N, Tonani S, Santamaria V, Brambilla E, Nappi R . Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome. Horm Behav. 2012; 63(1):65-71. DOI: 10.1016/j.yhbeh.2012.10.013. View

2.
Rowland D, McNabney S, Mann A . Sexual Function, Obesity, and Weight Loss in Men and Women. Sex Med Rev. 2017; 5(3):323-338. DOI: 10.1016/j.sxmr.2017.03.006. View

3.
Steffen K, King W, White G, Subak L, Mitchell J, Courcoulas A . Changes in Sexual Functioning in Women and Men in the 5 Years After Bariatric Surgery. JAMA Surg. 2019; 154(6):487-498. PMC: 6584276. DOI: 10.1001/jamasurg.2018.1162. View

4.
Derogatis L, Rosen R, Leiblum S, Burnett A, Heiman J . The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002; 28(4):317-30. DOI: 10.1080/00926230290001448. View

5.
Thannickal A, Brutocao C, Alsawas M, Morrow A, Zaiem F, Murad M . Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2020; 92(4):338-349. DOI: 10.1111/cen.14153. View